155 related articles for article (PubMed ID: 38218011)
1. n-3 polyunsaturated fatty acids alleviate the progression of obesity-related osteoarthritis and protect cartilage through inhibiting the HMGB1-RAGE/TLR4 signaling pathway.
Xiong T; Huang S; Wang X; Shi Y; He J; Yuan Y; Wang R; Gu H; Liu L
Int Immunopharmacol; 2024 Feb; 128():111498. PubMed ID: 38218011
[TBL] [Abstract][Full Text] [Related]
2. Dietary Fatty Acid Regulation of the NLRP3 Inflammasome via the TLR4/NF-
Jin X; Dong X; Sun Y; Liu Z; Liu L; Gu H
Oxid Med Cell Longev; 2022; 2022():3711371. PubMed ID: 35571243
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhizin regulates rat TMJOA progression by inhibiting the HMGB1-RAGE/TLR4-NF-κB/AKT pathway.
Hu Z; Xiao M; Cai H; Li W; Fang W; Long X
J Cell Mol Med; 2022 Feb; 26(3):925-936. PubMed ID: 34953035
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.
Chen YJ; Sheu ML; Tsai KS; Yang RS; Liu SH
PLoS One; 2013; 8(6):e66611. PubMed ID: 23776688
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
Sachdev U; Cui X; Tzeng E
J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
[TBL] [Abstract][Full Text] [Related]
7. Dietary omega-3 polyunsaturated fatty acids attenuate hepatic ischemia/reperfusion injury in rats by modulating toll-like receptor recruitment into lipid rafts.
Kim K; Jung N; Lee K; Choi J; Kim S; Jun J; Kim E; Kim D
Clin Nutr; 2013 Oct; 32(5):855-62. PubMed ID: 23395256
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury.
Chen X; Chen C; Fan S; Wu S; Yang F; Fang Z; Fu H; Li Y
J Neuroinflammation; 2018 Apr; 15(1):116. PubMed ID: 29678169
[TBL] [Abstract][Full Text] [Related]
9. Hyperbaric oxygen inhibits the HMGB1/RAGE signaling pathway by upregulating Mir-107 expression in human osteoarthritic chondrocytes.
Lin SS; Yuan LJ; Niu CC; Tu YK; Yang CY; Ueng SWN
Osteoarthritis Cartilage; 2019 Sep; 27(9):1372-1381. PubMed ID: 31146014
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of vascular HMGB1 and RAGE expression by n-3 polyunsaturated fatty acids is accompanied by amelioration of chronic vasculopathy of small bowel allografts.
Wei W; Chen M; Zhu Y; Wang J; Zhu P; Li Y; Li J
J Nutr Biochem; 2012 Oct; 23(10):1333-40. PubMed ID: 22217518
[TBL] [Abstract][Full Text] [Related]
11. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
Chandrashekaran V; Seth RK; Dattaroy D; Alhasson F; Ziolenka J; Carson J; Berger FG; Kalyanaraman B; Diehl AM; Chatterjee S
Redox Biol; 2017 Oct; 13():8-19. PubMed ID: 28551086
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits the development of obesity-related osteoarthritis via the TLR4 and PI3K/Akt signaling pathways.
Xu X; Liu X; Yang Y; He J; Gu H; Jiang M; Huang Y; Liu X; Liu L
Connect Tissue Res; 2019 Nov; 60(6):571-582. PubMed ID: 30922122
[No Abstract] [Full Text] [Related]
13. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
14. Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation.
Moraes TR; Veras FP; Barchuk AR; Nogueira ESC; Kanashiro A; Galdino G
Front Immunol; 2024; 15():1303937. PubMed ID: 38384464
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells.
Ojo OO; Ryu MH; Jha A; Unruh H; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1354-66. PubMed ID: 26432865
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
17. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
18. Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4.
Zhong H; Li X; Zhou S; Jiang P; Liu X; Ouyang M; Nie Y; Chen X; Zhang L; Liu Y; Tao T; Tang J
J Immunol; 2020 Aug; 205(3):767-775. PubMed ID: 32580932
[TBL] [Abstract][Full Text] [Related]
19. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
20. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
